Comparative effects of aspirin, a synthetic thrombin inhibitor and a monoclonal antiplatelet glycoprotein IIb/IIIa antibody on coronary artery reperfusion, reocclusion and bleeding with recombinant tissue-type plasminogen activator in a canine preparation
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 16 (3) , 714-722
- https://doi.org/10.1016/0735-1097(90)90364-u
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Tissue-Type Plasminogen ActivatorDrugs, 1989
- Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.Journal of Clinical Investigation, 1989
- A canine model of coronary artery thrombosis with superimposed high grade stenosis for the investigation of rethrombosis after thrombolysisJournal of the American College of Cardiology, 1989
- Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Controlled comparison with intracoronary streptokinaseJournal of the American College of Cardiology, 1988
- Intracoronary prostaglandin E1 plus streptokinase in acute myocardial infarctionThe American Journal of Cardiology, 1986
- Coronary thrombolysis with recombinant tissue-type plasminogen activator: Patency rate and regional wall motion after 3 monthsJournal of the American College of Cardiology, 1986
- Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina.Heart, 1985
- Effect of dextran and aspirin on platelet adherence after transluminal angioplasty of normal canine coronary arteriesThe American Journal of Cardiology, 1984
- Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.Circulation, 1983
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957